This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.
1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors
ePostersLive by SciGen Technologies S.A. All rights reserved.
September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas
CLL - 353
Chronic Lymphocytic Leukemia (CLL)
BGB-16673 (TACABRUTIDEG), A POTENT BTK DEGRADER IN HUMAN BLOOD AND CANCER CELL LINES, SHOWS HIGH SELECTIVITY IN BOTH PROTEOMICS AND KINOME PANEL ANALYSES